Adult adenovirus infections: Loss of orphaned vaccines precipitates military respiratory disease epidemics

Clinical Infectious Diseases

Volumn 31, Issue 3, 2000, Pages 663-670

  Gray, G C ^a   Goswami, P R ^a   Malasig, M D ^a   Hawksworth, A W ^a   Trump, D H ^a   Ryan, M A ^a   Schnurr, D P ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORPHAN DRUG; VIRUS VACCINE;

ADENOVIRUS; ARMY; ARTICLE; EPIDEMIC; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; VACCINE PRODUCTION; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADULT; DISEASE OUTBREAKS; HUMANS; MILITARY PERSONNEL; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; VIRAL VACCINES;

EID: 0034456968     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313999     Document Type: Article

References (77)

1. Respiratory diseases among US military personnel: Countering emerging threats
2. Acute respiratory disease in the military
3. Influence of crowding on respiratory illness in a large naval training station
4. Psychological stress and susceptibility to the common cold
5. Acute respiratory disease in the United States Army in the Republic of Vietnam, 1965-1970
6. Epidemiological investigations with respiratory disease virus RI-67
7. Appraisal of occurrence of adenovirus-caused respiratory illness in military populations
8. Outbreak of acute respiratory illness caused by RI-67 and influenza A viruses, Fort Leonard Wood, 1952-53
9. Studies on acute respiratory illness in naval recruits with emphasis on the adenoviruses (APC-RI)
10. Fatal pneumonia associated with adenovirus type 7 in three military trainees
11. Adenovirus vaccines in the US military
12. Reemergence of adenovirus type 4 acute respiratory disease in military trainees: Report of an outbreak during a lapse in vaccination
13. Observations and maintenance of inoculated cell cultures
14. Quantitative colorimetric microneutralization assay for characterization of adenoviruses
15. Worldwide epidemiology of human adenovirus infections
16. Computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables
17. An outbreak of adenovirus illness in navy recruits
18. The first reported outbreak of respiratory disease due to adenovirus type 4 in otherwise healthy young women
19. Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in US Army trainees
20. Vaccination with live type 4 adenovirus: Evaluation of antibody response and protective efficacy
21. Epidemiology of nonbacterial pneumonia among naval recruits
22. Epidemiology of adenovirus respiratory infections in military recruit populations
23. Respiratory disease and the adenoviruses
24. Control of adenovirus acute respiratory disease in US Army trainees
25. Bacterial pneumonia complicating adenoviral pneumonia: A comparison of respiratory tract bacterial culture sources and effectiveness of chemoprophylaxis against bacterial pneumonia
26. Fatal nonbacterial pneumonia associated with Adenovirus type 4: Occurrence in an adults
27. Efficacy of and indications for use of adenovirus vaccine
28. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers
29. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. Specific protective effect against epidemic disease
30. Adenoviral infection in military recruits: Emergence of type 7 and type 21 infections in recruits immunized with type 4 oral vaccine
31. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans
32. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7
33. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines
34. Live and inactivated adenovirus vaccines: Clinical evaluation of efficacy in prevention of acute respiratory disease
35. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines: Protection and lack of emergence of otlher types
36. Mass enteric live adenovirus vaccination during epidemic ARD
37. An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines
38. Simultaneous administration of live, enteric-coated adenovirus types 4, 7, and 21 vaccines: Safety and immunogenicity
39. Adenovirus infections in Chinese army recruits on Taiwan
40. Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits
41. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey
42. Impact of adenoviruses in human disease
43. Clinical picture and epidemiology of adenovirus infections
44. Disseminated adenovirus disease in immunocompromised and immunocompetent children
45. Type 7 adenovirus pneumonia
46. Adenovirus type 7 outbreak in a pediatric chronic-care facility - Pennsylvania, 1982
47. Outbreak of severe infection due to adenovirus type 7 in a paediatric ward in Japan
48. An outbreak of adenovirus type 7 infection in children in Montreal
49. Viruses and disease. III. An outbreak of adenovirus type 7A in a children's home
50. Civilian outbreak of adenovirus acute respiratory disease - South Dakota, 1997
51. Acute respiratory illnesses in university (1962-1966), military and industrial (1962-1963) populations
52. Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: Results of a retrospective nationwide seroprevalence survey
53. Outbreak of adenovirus 35 pneumonia among adult residents and staff of a chronic care psychiatric facility
54. An outbreak of respiratory disease due to a type 5 adenovirus identified as genome type 5a
55. Molecular epidemiology of adenoviruses: Alternating appearance of two different genome types of adenovirus 7 during epidemic outbreaks in Europe from 1958 to 1980
56. Adenovirus 37: Identification and characterization of a medically important new adenovirus type of subgroup D
57. Trend of adenovirus type 7 infection, an emerging disease in Japan: A report of the National Epidemiological Surveillance of Infectious Agents in Japan
58. Adenovirus surveillance, 1982-1993, Japan: A report of the National Epidemiological Surveillance of Infectious Agents in Japan
59. Molecular epidemiology of adenovirus type 7 in Israel: Identification of two new genome types, Ad7k and Ad7d2
60. Vaccines, pharmaceutical products, and bioterrorism: Challenges for the US Food and Drug Administration
61. Vaccines in civilian defense against bioterrorism
62. Contaminated polio vaccines: Will the next shot be fired in the courtroom?
63. Rotavirus, other vaccines encounter bumpy road
64. Historical trends related to bioterrorism: An empirical analysis
65. The US orphan drug programme 1983-1995
66. No-fault vaccine insurance: Lessons from the National Vaccine Injury Compensation Program
67. Developing technologies to address emerging infections
68. Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine
69. Patterns of adenovirus infection in the respiratory diseases of naval recruits
70. Prevention of adenoviral acute respiratory disease in Army recruits: Cost-effectiveness of a military vaccination policy